Temperature as a Neglected Variable in Cancer: Cell-Intrinsic Thermal Sensitivity, Fever-Range Immunity, and the Febrile Paradox
- 1Molecular Oncology and Immunotherapy, Clinic of General Surgery, University Medical Center Rostock, 18057 Rostock, Germany
- 2Clinic of General Surgery, University Medical Center Rostock, 18057 Rostock, Germany
Abstract
Temperature is a fundamental physical variable affecting protein folding, proteostasis, cell-cycle kinetics, and immune function, yet cancer cell biology is performed almost exclusively at a fixed 37 °C, and distinct thermal phenomena are often conflated under the single term “hyperthermia.” This review examines the biology of mild, fever-range temperature excursions of approximately 38–41 °C, which are mechanistically distinct from externally induced hyperthermia. We synthesize three strands of evidence that have rarely been considered together. First, tumor cells display heterogeneous thermal sensitivity, with differences in growth, cell-cycle responses, and thermal tolerance that may reflect intrinsic molecular features and proteostatic reserve, including the heat-shock response mediated by HSF1 and HSP70/HSP90. Second, fever-range temperatures remodel antitumor immunity across innate and adaptive compartments, affecting immune-cell trafficking, membrane organization, metabolism, and tumor–immune recognition. Third, the clinical record appears controversial: febrile infections have been associated with lower subsequent cancer risk, whereas postoperative fever has been associated with worse prognosis. We argue that these observations cannot be interpreted without considering host state, timing, and the biological context in which temperature elevation occurs. The three evidence streams are of unequal strength: cell-intrinsic thermal sensitivity and fever-range immune effects rest on direct experimental data, much of it from colorectal cancer, which we adopt as the principal proof-of-concept model, whereas the clinical associations are largely retrospective, and we treat them with correspondingly different confidence. We therefore frame a central testable question: is cell-intrinsic thermal sensitivity a cause or a correlate of fever’s effects on cancer? We propose an experimental agenda that separates cell-autonomous thermal responses from host-mediated effects and establishes temperature as an explicit, biologically informative variable in cancer research.
Related
- Temperature-dependent replication and sensitivity to innate immunity of human coronavirus HKU1
- Virion Factors That Target Daxx To Overcome Intrinsic Immunity
- Tumor-intrinsic PTPN12 suppresses anti-tumor immunity in colorectal cancer by restraining a dual epigenetic and cytoskeletal dsRNA sensing program
- Intrinsic connectivity signatures of anxiety sensitivity from connectome based predictive modeling
- CD4+ T cell-intrinsic T-bet sustains protective CNS immunity and parasite control during Toxoplasma gondii infection
BibTeX
@article{linnebacher2026temperature,
title = {{Temperature as a Neglected Variable in Cancer: Cell-Intrinsic Thermal Sensitivity, Fever-Range Immunity, and the Febrile Paradox}},
author = {Michael Linnebacher and Sandra Schwarz and Clemens Schafmayer},
journal = {Cells},
year = {2026},
month = oct,
doi = {10.3390/cells15211967},
url = {https://www.mdpi.com/2073-4409/15/21/1967},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Temperature as a Neglected Variable in Cancer: Cell-Intrinsic Thermal Sensitivity, Fever-Range Immunity, and the Febrile Paradox
AU - Michael Linnebacher
AU - Sandra Schwarz
AU - Clemens Schafmayer
PY - 2026
DA - 2026/10/28
JO - Cells
DO - 10.3390/cells15211967
UR - https://www.mdpi.com/2073-4409/15/21/1967
AB - Temperature is a fundamental physical variable affecting protein folding, proteostasis, cell-cycle kinetics, and immune function, yet cancer cell biology is performed almost exclusively at a fixed 37 °C, and distinct thermal phenomena are often conflated under the single term “hyperthermia.” This review examines the biology of mild, fever-range temperature excursions of approximately 38–41 °C, which are mechanistically distinct from externally induced hyperthermia. We synthesize three strands of evidence that have rarely been considered together. First, tumor cells display heterogeneous thermal sensitivity, with differences in growth, cell-cycle responses, and thermal tolerance that may reflect intrinsic molecular features and proteostatic reserve, including the heat-shock response mediated by HSF1 and HSP70/HSP90. Second, fever-range temperatures remodel antitumor immunity across innate and adaptive compartments, affecting immune-cell trafficking, membrane organization, metabolism, and tumor–immune recognition. Third, the clinical record appears controversial: febrile infections have been associated with lower subsequent cancer risk, whereas postoperative fever has been associated with worse prognosis. We argue that these observations cannot be interpreted without considering host state, timing, and the biological context in which temperature elevation occurs. The three evidence streams are of unequal strength: cell-intrinsic thermal sensitivity and fever-range immune effects rest on direct experimental data, much of it from colorectal cancer, which we adopt as the principal proof-of-concept model, whereas the clinical associations are largely retrospective, and we treat them with correspondingly different confidence. We therefore frame a central testable question: is cell-intrinsic thermal sensitivity a cause or a correlate of fever’s effects on cancer? We propose an experimental agenda that separates cell-autonomous thermal responses from host-mediated effects and establishes temperature as an explicit, biologically informative variable in cancer research.
SN - 2073-4409
ER -